Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Bijan Bastani"'
Autor:
Paula K. Schweitzer, Russell Rosenberg, Gary K. Zammit, Mark Gotfried, Dan Chen, Lawrence P. Carter, Hao Wang, Yuan Lu, Jed Black, Atul Malhotra, Kingman P. Strohl, Adam Blackman, Charles George, Colin Shapiro, Heike Benes, Ingo Fietze, Geert Mayer, Peter Young, Gert Jan Lammers, Mansoor Ahmed, Akinyemi Ajayi, James Andry, Roy Artal, Bijan Bastani, Richard Bogan, Bruce Corser, Christopher Drake, Helene Emsellem, Milton Erman, Neil Feldman, Nancy Foldvary, John Hudson, Lois Krahn, Daniel Lorch, James Maynard, Emmanuel Mignot, Michael Neeb, Joseph Ojile, Alvin Thomas Perkins, Asim Roy, Pradeep Sahota, R. Bart Sangal, Andrew Schreiber, Paula Schweitzer, Ralph Steele, Thomas Stern, Sarah Stolz, Kingman Strohl, Todd Swick, Todd J. Swick, Stephen G. Thein, Robert Thomas, Michael Thorpy, Terri Weaver, Kerri Wilks, David Winslow, Paul Wylie, Gary Zammit, Phyllis Zee
Publikováno v:
American Journal of Respiratory and Critical Care Medicine
Rationale: Primary treatment of obstructive sleep apnea can be accompanied by a persistence of excessive sleepiness despite adherence. Furthermore, effectiveness of sleep apnea treatment is limited by poor adherence. Currently available pharmacologic
Autor:
Bijan Bastani, David V. Sheehan, Thomas Roth, Gregory M. Asnis, Ram K. Shrivastava, Maurizio Fava, Bruce Lydiard
Publikováno v:
Journal of Clinical Psychopharmacology. 29:222-230
A multicenter, double-blind, parallel-group study was designed to assess the efficacy and safety of zolpidem extended-release coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Patients (N = 383) rec
Autor:
Mahmoud A. Parsa, Bijan Bastani
Publikováno v:
The Journal of Neuropsychiatry and Clinical Neurosciences. 10:216-219
Psychoses are a common clinical problem in patients with Parkinson's disease. Treatment with typical neuroleptics or withdrawal of antiparkinsonian drugs may improve mental symptoms but will worsen the parkinsonism. Quetiapine (Seroquel), ICI 204,636
Autor:
Ram K. Shrivastava, David V. Sheehan, Gregory M. Asnis, Maurizio Fava, Bruce Lydiard, Thomas Roth, Bijan Bastani
Publikováno v:
The Journal of clinical psychiatry. 72(7)
OBJECTIVE: This investigation was performed to assess the efficacy and safety of zolpidem extended-release in patients with insomnia associated with major depressive disorder (MDD). METHOD: Patients (N = 385) received open-label escitalopram 10 mg/d
Publikováno v:
Psychiatric Services. 41:892-897
The effect of approximately six months of treatment with clozapine on the quality of life of 38 treatment-resistant schizophrenic patients was prospectively studied in an open trial. The Quality of Life Scale was used to provide an objective measure
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 17(1)
It has been suggested that the clinical efficacy of chronic treatment with selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine and perhaps all antidepressants is due to their ability to enhance serotonergic activity. The effects of chr
Autor:
Marilyn A. Davies, Bijan Bastani, Philip A. Cola, Herbert Y. Meltzer, Lynne E. Way, Beth E. Snitz, Paul M. Thompson
Publikováno v:
The American journal of psychiatry. 150(11)
Objective The goal of this study was to determine whether clozapine is a cost-effective treatment for treatment-resistant schizophrenia. Method Data were collected on 96 treatment-resistant patients with schizophrenia for 2 years before they entered
Publikováno v:
Biological psychiatry. 30(2)
14C-Serotonin (5-HT) uptake and 3H-imipramine binding (IB) were studied in the blood platelets of 20 obsessive-compulsive disorder (OCD) patients, 53 normal controls (5-HT uptake) and 32 normal controls (IB binding). The maximum number of binding sit
Publikováno v:
Biological Psychiatry. 47:S163
Publikováno v:
Psychopharmacology.
The Clozaril Patient Management System (CPMS) has been developed to provide a 100% fail-safe system for monitoring white blood cell counts (WBCs) in patients being treated with clozapine (Clozaril/Leponex) in the United States and to provide comprehe